Mike Bonney (Cubist Pharmaceuticals)
Mike Bonney (Cubist Pharmaceuticals)
Cubist - Battling Superbugs: The Intersection of Science and Policy
Cubist - Battling Superbugs: The Intersection of Science and Policy
Cubist, the world’s largest company focused on the discovery, development and commercialization of antibiotics with activity against highly resistant bacteria, located in Lexington MA, was recently acquired by Merck. Michael Bonney, the CEO of the company from 2003 will discuss the development of the company and the current state of r and d in this critical area of public health. Particular focus will be paid to the inherent challenges of attracting capital to support the investment in r and d given the appropriate use of antibiotics and the resultant international public health crisis as bacteria continue to develop resistance and the investment in r and d has dropped precipitously over the past 20-30 years.
Light lunch will be provided for attendees.
To RSVP or for questions on a seminar or to join the mailing list or arrange parking, please contact sbbi@hbs.edu.
If you know of someone who would like to be added to the distribution list or if you would like to be removed from the list, please let us know at any time.